Top Story

NCCN appoints interim VP of oncology research program

December 1, 2015

The National Comprehensive Cancer Network appointed Robert C. Young, MD, as interim vice president of the NCCN Oncology Research Program.

Young — recognized for his treatment of lymphoma and ovarian cancer — is president of RCY Medicine, a consulting service focused on cancer center productivity, health care quality and health policy. He served as president and CEO of Fox Chase Cancer Center for 18 years, and he later served 2 years as chancellor.

Early, open communication required when involving adolescents in cancer care plans

December 1, 2015
When an adolescent or young adult receives a cancer diagnosis, their life is completely interrupted.They miss school for periods of time, they may lose their hair, and…
Meeting News Coverage

Top Takeaways from ASCO: Esophageal cancer

December 1, 2015
CHICAGO — Heart disease-related death among patients with esophageal cancer who are treated with radiation may be detectable as early as 8 months from diagnosis…
FDA News

FDA grants orphan drug designation to marizomib for malignant glioma

December 1, 2015
The FDA granted orphan drug designation to marizomib for the treatment of patients with malignant glioma, according to a press release from the drug’s…
In the Journals

Portal veinous blood test may improve diagnosis, treatment of pancreatic cancers

December 1, 2015
Sampling portal venous blood via endoscopic ultrasound was found to be safe and feasible for counting circulating tumor cells in patients with pancreaticobiliary…
More News Headlines »

NSCLC Treatment on Target: Examining New Evidence and Advances

This activity is supported by an educational grant from Genentech, Inc. and Merck & Co., Inc.

Globally, lung cancer is the leading cause of cancer-related deaths. Eighty five percent of lung cancers are non-small…
More »
Meeting News Coverage Video

HPV vaccination falling short due to providers, not parents

November 22, 2015
More »

The Patient with Non-Small Cell Lung Cancer

No commercial support for this activity.

The management of non-small cell lung cancer (NSCLC) has evolved in the past decade, as advances are made in diagnosis…
More »
Current Issues
View the Current Issue
HemOnc Today
morganatic-roan morganatic-roan